Sometimes I ask myself if this company can do anything right.

This weakness in the share price seems unwarranted.

GLTA.

Anyone adding on today's dip besides me?

GLTA.

One thing I've noticed as I watch ECTE throughout the day is that is gets hammered down a bit during the day and mysteriously rebounds to even or up a penny by the end of the day. Seems like this could be shorting to make small daily gains.

I added 1,000 shares at 2.19 and how nice to see 2.14 print soon after.

Let's go!

Maybe the pps is going down because another share offering is coming...I don't want one, but nothing will surprise me with this sham of a company.

What a waste to dump 122,000 shares yesterday when the pps is 2.99 today. $14,000 lost to drive the pps down? Is this short wisdom?

If so, I'll have my finger on the buy button at 3:59 today for another bargain.

GLTA.

A buyout is fine by me as long as the pps is at least 7.50.

GLTA.

The new IR firm that came on board several months ago can start earning their money anytime now...

Thanks for clarifying that - a 1 for 100, or even a 1 for 500 stock dividend might be nice (but also unlikely at this stage in the company's life).

Some NAVB posters have suggested that a dividend would force an audit of the short position. If this is true, even a .01 per share dividend would suffice. It could be declared at 4:00PM on any given day for shareholders of record as of 4PM. It would be small surprise bonus for loyalty and simultaneously, ram it to Tang, Marty, and others that have wrongfully harmed our tiny biotech.

It would only cost the company $1.2 million and the shorts would have to pay the dividend on all short shares. The company has the resources to do this, and should do it, if for no other reason than to BUILD SHAREHOLDER VALUE by putting the shorts on notice.

Yes, Brent. The screaming is directed at you specifically.

GLTA.

The more I think about it, the shorts seem to be ignoring the line of credit by pulling stunts like restricting the pps all day long. IMO, the company can outlast the shorts.

NAVB reached 3.21 a few weeks back without news. Today we had three pieces of news disregarded and degraded by short sellers to the extent that we could not hold 3.00. One thing I'm sure of is that the shorts do not have another 1.5 million shares to stifle us with again tomorrow.

Of course, short covering that has occurred over the past 2-3 months has freed up the same shares to be reshorted.

GLTA.

Because of the GE line of credit, I also added today. It was disgusting to see the pps bottom at 2.87 on a 122,000 share dump. My instinct is that the pps will rebound tomorrow and test 3.00.

We'll see.

GLTA.

I just tried to call Brent Larson and was told he is in a meeting.

With an .11 decline on a day with three news releases, I'm sure he is...

What will tomorrow bring? And when the hell will we hear about the European Partnership?

GLTA.

.007 only works for James Bond. WTF is going on with JADA?

The big bidder is hiding again.

The end of the day buyers and surges are back. Go figure. News tomorrow?

GLTA.

Thanks. I had not seen the 2 forms yet, though I had read elsewhere that an amended form was coming. Platinum Montaur has been very supportive of the company for years. If the mistake was theirs, perhaps it was just that, a mistake.

I believe that the "error" in reporting Montaur's status as being sold out was a deliberate (and potentially criminal misrepresentation) on the part of some third party that made it happen. I don't know if the shorts made it happen or some other crooked party did it somehow, but I believe it was an attempt to create a real panic. What a wasted effort.

DDbuyer posted months ago following the post-Lymposeek approval NAVB pps decline that he spoke to a reliable source at Platinum Montaur and was assured by whoever he spoke with that Platinum was not selling at the time. This past week, I was thinking someone there lied to him - but, he was right and was given true information.

The "error" was unsuccessful, whatever it was. While NAVB closed at 2.78 on Friday, my sense is that we are headed back up throughout August and into the Fall...too much great stuff is happening in the background that we already know about...and perhaps even more that we soon will. The company has expanded its staff multiple times over the past 18 months...

GLTA.

Nice post - and fwiw I think many of the Oldtimers also believe a real squeeze is possible here (as do I) but they do not openly post about it much since it might only be seen as self-serving or as hopeful speculation by onlookers. But imo, the short interest is simply too high with too much simultaneous GREAT stuff happening behing the scenes for NAVB to not soar higher sooner than later.

And speaking of shorting, another short report should be out soon...tomorrow maybe? I think another 500,000+ share decrease in the short position is coming, perhaps 1,000,000 shares.

GLTA.

One Oldtimer says we go down tomorrow no matter what...I say the European partnership announced WITH sales could push us over the top.

And with that partnership announcement coming sooner than later, shorting NAVB tomorrow into good news is unwise.

GLTA.

The short interest is down another 911,165 shares. Gradual short covering should stabilize the price at 3.00 for now and ultimately much higher. Much good news is expected and I see very little downside from here in the way of unexpected bad news. Oh Europe, oh Europe!

GLTA.

Congratulations to all buyers over the past 3 months. Things have turned our way, and they appear to only be gaining momentum. After the partnership details are announced, we still have 2 new NDAs to look forward to along with a host of other catalysts. NAVB is still a bargain at 3.00.

GLTA.

Sales are important, but it is important to remember that the first sales report does not represent a full quarter. The more sales the better in the first sales report, but I have said before that it may take several quarters for Lymphoseek to gain its due exposure in its market - then again, maybe it won't. GE put up millions of dollars based on something...Some have posted that sales must be off to a stellar start and this impressed GE. I'm definitely impressed with the NAVB management team (that has expanded several times over the past 12 months).

I agree that the shorts were winning everyday all day from Lymphoseek approval until recently, but things seems to be turning around. There has been an abundance of news that is now getting some collective attention. Our end of the day buys in large blocks are back. I don't expect 4.00 tomorrow, but I do expect it within 12 months.

I do not expect the short interest to show an increase in the coming report or the one after it. I expect the EU partnership news to create an amazing run.

I have said many times about NAVB, "Expect the unexpected."

For me, the GE financing was a welcome, though unexpected positive development.

I hated seeing NAVB in the 2.40s but would now happily be a buyer if any sellers are fool enough to send NAVB back there.

I understand your frustration and share it - but I believe we have turned a corner and that 3.00 is not that far off.

GLTA.

I agree that the noose is tightening on the shorts. I also believe that it is possible that institutions are buying in the large blocks at the end of the day, rather than it being short covering. Either way, with the GE financing that was recently announced, the shorts will either be covering sooner than later or making the inevitable squeeze all that much worse for themselves if they wait.

There seems to be very little downward pressure at the moment, but there is also minimal volume - not good for the shorts in either case.

Enjoy the weekend everyone.

GLTA.

Exactly right.

It does not seem as if there has been much shorting or downward pressure for at least 5 trading days. It seems as if the higher and higher interest rate to short NAVB and a simultaneous shortage of shares to short may be moving NAVB up little by little.

And news like that from today and yesterday certainly helps as well.

Without a secondary offering (which now seems exceptionally unlikely), the shorts will have to cover. Large funds that have been considering NAVB can put 2 and 2 together and start the short squeeze themselves. With all of the good news we have had since Lymphoseek approval, it seems as if 3.00 could be back in a flash.

Cheers.

GLTA.

Well, the trouble all started when 2 of 5 customers did not pay their bill and the company simultaneously stopped reporting. If the deadbeats have paid up and we get the necessary SEC filing, I think JADA could head back to .20 and stay above it. They have a 50 year lease on the Jade mountain and great demand for the Jade. The old website was impressive and if the company was legitimate at the time, I still believe its best days are yet to come.

GLTA.

50,000 shares were just bought at the ASK of .0156 - this is starting to MOVE.

Our volume is just over 300,000. This is surprising considering the strong GEC financing news. Volume totaling 500,000 shares on the day will not surprise me as we have seen plenty of days with large volume in the final minutes.

GLTA.

The BID has increased to .013. Someone wants 2.94% of the company for $23,526.

My theme on NAVB has been "Expect the unexpected."

I never expected another line of credit extension and I can't recall any poster anywhere that suggested it was a real possibility.

Today I expect the pps to rise further. I also expect more short covering over the next 30 days.


GLTA.

Randy - can you call when you have a minute? Thanks.

I am also disgusted with the lack of developments here.

Calling TW - are you out there?

I am disgusted that in February this stock was in the 1.20 range and the company destroyed this progress with the offering at .75. And now the equivalent price is .24.

Will we ever see justice?

The new blockbuster movie hit of the summer:

Echo Theraputics: Into Darkness

Tagline: You think your stock is low, just look at ours!

Plot Summary: A bunch of incompetent managers and executives at Echo Theraputics force their company into bankruptcy after numerous share offerings and poor management decisions. Shareholders were angry and tried to get compensated, but the films villain (Mooney) just laughed and kept doing nothing to build shareholder value.

2.85. Disgusting. EOM.

Indeed - it did not seem as though the shorts could keep any pressure on NAVB in the last 15 minutes of trading today.

GLTA.